Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Albemarle Corporation is a specialty chemicals business based in the US. Albemarle Corporation shares (ALB) are listed on the NYSE and all prices are listed in US Dollars. Albemarle Corporation employs 5,900 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$228.77|
|52-week range||$89.25 - $252.67|
|50-day moving average||$227.66|
|200-day moving average||$189.70|
|Wall St. target price||$230.95|
|Dividend yield||$1.55 (0.67%)|
|Earnings per share (TTM)||$6.33|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||6.37%|
|1 month (2021-09-17)||0.85%|
|3 months (2021-07-17)||36.25%|
|6 months (2021-04-16)||50.48%|
|1 year (2020-10-16)||144.88%|
|2 years (2019-10-17)||235.34%|
|3 years (2018-10-17)||137.51%|
|5 years (2016-10-17)||181.53%|
Valuing Albemarle Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Albemarle Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Albemarle Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Albemarle Corporation shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Albemarle Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2578. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Albemarle Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Albemarle Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $821.2 million.
The EBITDA is a measure of a Albemarle Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.2 billion|
|Operating margin TTM||17.87%|
|Gross profit TTM||$996.9 million|
|Return on assets TTM||3.44%|
|Return on equity TTM||14.82%|
|Market capitalisation||$26.8 billion|
TTM: trailing 12 months
There are currently 1.7 million Albemarle Corporation shares held short by investors – that's known as Albemarle Corporation's "short interest". This figure is 29.1% down from 2.4 million last month.
There are a few different ways that this level of interest in shorting Albemarle Corporation shares can be evaluated.
Albemarle Corporation's "short interest ratio" (SIR) is the quantity of Albemarle Corporation shares currently shorted divided by the average quantity of Albemarle Corporation shares traded daily (recently around 1.2 million). Albemarle Corporation's SIR currently stands at 1.41. In other words for every 100,000 Albemarle Corporation shares traded daily on the market, roughly 1410 shares are currently held short.
However Albemarle Corporation's short interest can also be evaluated against the total number of Albemarle Corporation shares, or, against the total number of tradable Albemarle Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Albemarle Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Albemarle Corporation shares in existence, roughly 10 shares are currently held short) or 0.0148% of the tradable shares (for every 100,000 tradable Albemarle Corporation shares, roughly 15 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Albemarle Corporation.
Find out more about how you can short Albemarle Corporation stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Albemarle Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 41.74
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Albemarle Corporation's overall score of 41.74 (as at 12/31/2018) is pretty weak – landing it in it in the 84th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Albemarle Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 21.59/100
Albemarle Corporation's environmental score of 21.59 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Albemarle Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.41/100
Albemarle Corporation's social score of 15.41 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Albemarle Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.74/100
Albemarle Corporation's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Albemarle Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Albemarle Corporation scored a 1 out of 5 for controversy – the highest score possible, reflecting that Albemarle Corporation has managed to keep its nose clean.
|Total ESG score||41.74|
|Total ESG percentile||84.08|
|Environmental score percentile||7|
|Social score percentile||7|
|Governance score percentile||7|
|Level of controversy||1|
Dividend payout ratio: 36.59% of net profits
Recently Albemarle Corporation has paid out, on average, around 36.59% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.68% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Albemarle Corporation shareholders could enjoy a 0.68% return on their shares, in the form of dividend payments. In Albemarle Corporation's case, that would currently equate to about $1.55 per share.
While Albemarle Corporation's payout ratio might seem fairly standard, it's worth remembering that Albemarle Corporation may be investing much of the rest of its net profits in future growth.
Albemarle Corporation's most recent dividend payout was on 30 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 15 September 2021 (the "ex-dividend date").
Albemarle Corporation's shares were split on a 2:1 basis on 1 March 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Albemarle Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Albemarle Corporation shares which in turn could have impacted Albemarle Corporation's share price.
Over the last 12 months, Albemarle Corporation's shares have ranged in value from as little as $89.2473 up to $252.6731. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Albemarle Corporation's is 1.5852. This would suggest that Albemarle Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.